Year
Edition number
№7 / 2021
CLINICAL RECOMMENDATIONS
Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment (clinical guidelines for therapists, third version)
7-43
ORIGINAL STUDIES
Geyvandova T.V., Rogova S.Sh.
Obesity, non-alcoholic fatty liver disease, and FTO oligonucleotide polymorphism44-49
Kozlova I.V., Kudishina M.M., Bykova A.P., Krylova Yu.S.
Pathology of the musculoskeletal system in inflammatory bowel diseases50-57
Koroy P.V., Kravchenko Yu.A., Yagoda A.V.
Family of selectins in non-alcoholic fatty liver disease58-63
Levitan B.N., Kasyanova T.R., Voloshina O.A., Martynova A.D.
Predictive value of studying lipopolysaccharide – binding protein in liver cirrhosis64-70
Mukhtarova A.V., Batyushin M.M., Sinelnik E.S., Antipova N.V., Gadaborsheva H.Z.
Influence of TGF-β1 expression on the development of tubulointerstitial fibrosis in patients with primary chronic glomerulonephritis71-76
Pavlenko V.V., Pavlenko A.F., Kazakova L.M.
Insulin-like growth factor IGF-I and bone metabolism in Crohn’s disease77-81
Saneeva G.A.
Musculoskeletal manifestations and prevalence of orthopedic pathology: clinical and diagnostic significance in case of joint hypermobility syndrome82-87
Tkachev A.V., Belovolova R.A., Mkrtchyan L.S., Mazovka K.E.
General patterns and regional features of epidemiology and the course of ulcerative colitis in the Rostov region88-94
Pereverzeva K.G., Yakushin S.S.
Estimation of the efficacy and safety of using the system of remote monitoring of patients after myocardial infarction95-103
REVIEWS
Shorina D.A., Osadchuk M.A., Lazareva A.E., Vasilieva I.N.
Irritable bowel syndrome in combination with functional dyspepsia: features of the course and prognosis of outcomes104-111
Osadchuk A.M., Osadchuk M.M., Zolotovskaya I.A.
Thrombotic complications in patients with liver cirrosis: current state of the problem112-117
Kuznetsova A.S., Genkel V.V., Dolgushina A.I., Shaposhnik I.I, Olevskaya E.R., Selyanina A.A., Khusainova G.M.
Non-alcoholic fatty liver disease and atherosclerosis: common mechanisms of development and progression118-125
Kostina N.E., Starodubtseva I.A., Sharapova Yu.A., Malyavin A.G.
Interstitial lung diseases, progressive phenotype: urgent problems of early diagnosis and early initiation of antifibrotic therapy126-131
Tarasova L.V., Dimitrieva O.V., Dolgov I.Yu., Elmurzayeva A.A.
Models of risk determination of cancer-associated thromboses132-137
GUIDELINES FOR PRACTITIONERS
Yagoda A.V., Belotserkovskaya M.I., Gladkikh N.N., Ushakova O.V.
Systemic form of panniculitis with damage of internal organs138-143
LECTURE
Musaeva L.N., Esedov E.M., Abasova A.S., Mammaev S.N.
Melatonin metabolism in health and disease of the gastrointestinal tract (literature review)144-151
Ponomareva E.Yu., Rebrov A.P.
Infective endocarditis in HIV-infected patients152-158
ACTUAL ISSUES OF PHARMACOTHERAPY
Pereverzev A.P., Ostroumova O.D.
Drug-induced hyperuricemia/gout. Part 2: certain medicines, the use of which is associated with an increased risk of developing of these diseases159-169
Activities of RNMOT
Digest events in SEPTEMBER 2021
170-177
JUBILEE
To the 90th anniversary of professor A.V. Tuev
178-179
WE REMEMBER
Andrey Apollonovich KIRICHENKO: August 4, 1950 — July 22, 2021 г.
180
